[研究报告] 水生兽医市场规模预计将从 2022 年的 14.5044 亿美元增长到 2030 年的 19.3433 亿美元;预计 2022-2030 年期间市场复合年增长率为 3.7%。
市场洞察和分析师观点:
水生兽医学科涉及对水生动物(包括鲸鱼、鲨鱼、鳄鱼、软体动物和企鹅)的完整医疗保健。 水生兽医市场的增长归因于各国政府为发展各自的水产养殖业而采取的举措以及对水生动物食品的需求激增。此外,持续开发新型鱼类疫苗的努力预计将在未来几年为市场参与者创造充足的机会。
增长动力和限制因素:
海鲜需求旺盛和野生鱼类年捕捞量减少是推动水产养殖业呈指数级增长的关键因素。因此,各国政府正在采取措施改善和支持水产养殖业的发展。
以下是一些最新举措:
- 2021年2月,食品与农业研究基金会(FFAR)筹集了790,326美元的资金,用于建立疫苗输送系统,防止罗非鱼湖病毒感染和水产养殖业中其他疾病的传播。
- 2022年1月,顶级水产养殖生物技术公司Benchmark Animal Health和世界领先的鲑鱼养殖公司Cermaq Group AS从挪威研究委员会获得40万美元(420万挪威克朗)的资助,以支持生产针对Tenacibaculum细菌引起的鲑鱼疾病的疫苗的合作研究项目。
- 2023 年 1 月,欧盟委员会向 PerformFISH 项目提供了 788 万美元的资助,该项目旨在探索和解决地中海海洋鱼类养殖 (MMFF) 行业停滞的主要原因。PerformFISH 一直在努力应对地中海水产养殖中与鲈鱼和鲷鱼相关的挑战。
欧盟 (EU) 在“地平线 2020”计划框架内资助了地中海水产养殖综合发展 (Media),这是一项为期四年的研究与创新行动 (RIA) 项目,与 PerformFISH 一起在 SFS-23-2016 计划下获得联合批准,旨在提高地中海水产养殖的技术性能。MedAID 旨在提高整个价值链中地中海海洋鱼类养殖业的可持续性和竞争力。因此,政府支持水产养殖业发展的举措不断增加,推动了水产兽医市场的增长。此外,水产兽医市场趋势包括开发针对不同鱼类病原体的新型 DNA 疫苗。
用于商业用途的鱼疫苗必须得到相应国家或地区主管部门的批准。在使用或交易疫苗之前,必须遵守相关主管部门制定的具体规则和建议。授权的立法、要求和相关监管机构可能因国家而异。在欧盟,鱼疫苗不能由国家主管部门授权。欧洲药品管理局为整个欧盟授权。生产疫苗的成本很高,因为欧盟对疫苗制造商有严格的良好生产规范 (GMP) 指导方针。鱼疫苗的市场比其他动物疫苗小,其开发成本高于其他动物物种的疫苗。在美国,FDA 批准鱼疫苗。鱼疫苗的开发需要 10 年以上甚至更长时间,成本接近 1000 万至 2000 万美元。此外,审批过程耗时,阻止新参与者进入市场。因此,严格的监管框架阻碍了鱼疫苗的开发和商业化,从而阻碍了水生兽医市场的增长。
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
报告细分和范围:
水生兽医市场分析已考虑以下几个部分:类型、疾病来源、物种和给药途径。 根据类型,市场分为诊断和治疗。根据物种,市场分为鱼类、甲壳类、软体动物和其他。根据疾病来源,市场分为细菌、病毒、寄生虫和其他。在给药途径方面,市场分为水药、药物饲料和其他。根据地理位置,水生兽医市场分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、俄罗斯和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度、韩国和亚太地区其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。
节段分析:
根据类型,水产兽医市场研究分为诊断和治疗。2022 年,治疗部分占据了更大的市场份额。预计该部分市场在 2022 年至 2030 年期间将以更高的复合年增长率增长。
根据物种,市场分为鱼类、甲壳类、软体动物和其他。鱼类在 2022 年占据了水生兽医市场的最大份额。预计 2022 年至 2030 年期间的复合年增长率最高。
根据疾病来源,市场分为细菌、病毒、寄生虫和其他。细菌部分在 2022 年占据了水生兽医市场的最大份额。预计在 2022-2030 年期间将实现最高的复合年增长率。
根据给药途径,水产兽医市场细分为水药、药用饲料和其他。水药部分在 2022 年占据了最大的市场份额。预计同一部分将在 2022 年至 2030 年期间实现最高复合年增长率。
区域分析:
水产兽医市场报告的范围包括北美、欧洲、亚太地区、南美和中美以及中东和非洲。2022 年,北美占据了最大的市场份额。北美水产兽医市场分为美国、加拿大和墨西哥。美国市场的增长归因于蓬勃发展的水产养殖业和对水产动物源性食品产品的需求激增。
根据《2020 年美国渔业报告》,美国商业渔民报告称,2020 年的渔获量为 84 亿磅,价值 47 亿美元。2020 年,美国钓鱼者进行了近 2 亿次休闲渔业活动。这些休闲钓鱼者捕获了大约 10 亿条鱼,其中 65% 被放生。休闲渔业总产量估计为 3.44 亿条鱼,重 3.53 亿磅。因此,蓬勃发展的水产养殖业推动了美国水产兽医市场的增长。
- 2020 年 9 月,维克集团从专门从事生物学研发的动物保健公司 Ictyogroup 收购了多种罗非鱼疫苗。该集团获得了在全球范围内分销和营销这些注册自生疫苗的权利。两家公司合作为 Aqua Virbac 部门开发新配方和新疫苗。该协议还允许将几名专门从事技术营销支持和生物学研发的员工从 Ictyogroup 调到维克。
- 2020 年 7 月,硕腾从 Benchmark Holdings, PLC 收购了 Fish Vet Group,为其制药业务增添了战略性内容。硕腾的制药业务负责鱼疫苗的商业化和开发,并为水产养殖提供疫苗接种和诊断服务。收购 Fish Vet Group 有助于硕腾增强其诊断专业知识和测试服务,包括在 Pharmaq 的参考实验室进行环境测试。
因此,美国水产养殖业各市场参与者的战略举措促进了美国水生兽医市场的发展。
行业发展和未来机遇:
水产兽医市场预测可以帮助该市场的利益相关者规划其增长战略。以下列出了水产兽医市场主要参与者采取的一些举措:
- 2020 年 9 月,AKVA 集团与 Vikings 签署了设计与合作协议,将在中东设计多个陆基鲑鱼养殖场。AKVA 集团在设计、建造和运营现代陆基养鱼场方面拥有丰富的经验。
- 2020 年 5 月,AKVA 集团收购了位于挪威海底集群诺托登镇的 Sperre。该公司在为水产养殖、石油服务和海洋产业开发和制造各种先进的 ROV 解决方案方面拥有丰富的经验。
- 2022 年 11 月,Elanco Animal Health Inc 和 Ginkgo Bioworks 推出 BiomEdit,致力于发现、开发和推出新型益生菌、生物活性分子、工程微生物药物和动物健康微生物监测服务。
- 2023 年 11 月,默克动物保健公司在其鱼类福利系列中推出了两个培训模块,为水产养殖企业和鱼类保护社区提供培训和最佳实践,以改善鱼类福利。这些培训计划还旨在补充和帮助满足水产养殖认证和管理计划的动物护理要求。
水产兽医市场区域洞察
Insight Partners 的分析师已详细解释了预测期内影响水生兽医市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的水生兽医市场细分和地理位置。

- 获取水产兽医市场的区域特定数据
水产兽医市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 14.5亿美元 |
2030 年市场规模 | 19.3亿美元 |
全球复合年增长率(2022 - 2030 年) | 3.7% |
史料 | 2020-2021 |
预测期 | 2023-2030 |
涵盖的领域 | 按类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
市场参与者密度:了解其对商业动态的影响
水产兽医市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在水生兽医市场运营的主要公司有:
- 梭鱼
- 硕腾
- 礼来动物保健
- 默克集团
- 维克动物保健公司
免责声明:上面列出的公司没有按照任何特定顺序排列。

- 获取水生兽医市场顶级关键参与者概览
竞争格局和重点公司:
Esox、Zoetis、Elanco Animal Health、Merck KgaA、Virbac Animal Health、Phbro Animal Health Corporation、Aquatic Diagnostics Ltd、Thermo Fisher Scientific、Ceva 和 HIPRA 是水产兽医市场报告中介绍的知名企业。这些公司为促进增长而采取的一些增长战略包括推出、扩张和搬迁。Elanco Animal Health Inc. 是实施有机战略的公司之一,这些战略反过来又带来了各种变化,对全球卫生经济和成果研究服务市场做出了重大贡献。除了上面提到的那些,研究过程中还研究和分析了其他几家参与者,以全面了解市场及其生态系统。
- 历史分析(2 年)、基准年、预测(7 年)及复合年增长率
- PEST 和 SWOT 分析
- 市场规模价值/数量 - 全球、区域、国家
- 行业和竞争格局
- Excel 数据集



Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
This text is related
to segments covered.

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
This text is related
to country scope.
常见问题
The aquatic veterinary medicine discipline involves complete healthcare for aquatic animals, including whales, sharks, alligators, mollusks, and penguins. The aquatic veterinary market size is growing with initiatives taken by various country governments to develop their respective aquaculture industries and the surging demand for food products derived from aquatic animals.
The global aquatic veterinary market, by type, is segmented into diagnostics and treatments. In 2022, the treatment segment accounted for a larger share of the market. The market for this segment is expected to grow at a higher CAGR from 2022 to 2030.
The global aquatic veterinary market majorly consists of the players such as Esox, Zoetis, Elanco Animal Health, Merck KgaA, Virbac Animal Health, Phbro Animal Health Corporation, Aquatic Diagnostics Ltd, Thermo Fisher Scientific, Ceva, and HIPRA
The aquatic veterinary market size is growing with initiatives taken by various country governments to develop their respective aquaculture industries and the surging demand for food products derived from aquatic animals. Further, ongoing efforts for the development of novel fish vaccines are expected to create ample opportunities for the aquatic veterinary market in the coming years.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Aquatic Veterinary Market
- Esox
- Zoetis
- Elanco Animal Health
- Merck KgaA
- Virbac Animal Health
- Phbro Animal Health Corporation
- Aquatic Diagnostics Ltd
- Thermo Fisher Scientific
- Ceva
- HIPRA
- Fish Vet Group
- MELAFIX
- Cenavisa Animal Health & Aquaculture
- Hebei Veyong pharmaceutical Co., Ltd.
- MED-VET BIOLINKS PRIVATE LIMITED
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.